Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Crizotinib 1.4.3 Alectinib 1.4.4 Ceritinib 1.4.5 Brigatinib 1.4.6 Other 1.5 Market by Application 1.5.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 ALK Positive Lung Cancer Treatment Market Perspective (2015-2026) 2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions 2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2015-2020) 2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 ALK Positive Lung Cancer Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key ALK Positive Lung Cancer Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top ALK Positive Lung Cancer Treatment Players by Market Size 3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2015-2020) 3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio 3.2.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2019 3.3 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served 3.4 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service 3.5 Date of Enter into ALK Positive Lung Cancer Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2015-2020) 4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2021-2026) 5 ALK Positive Lung Cancer Treatment Breakdown Data by Application (2015-2026) 5.1 Global ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America ALK Positive Lung Cancer Treatment Market Size (2015-2020) 6.2 ALK Positive Lung Cancer Treatment Key Players in North America (2019-2020) 6.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 6.4 North America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2015-2020) 7.2 ALK Positive Lung Cancer Treatment Key Players in Europe (2019-2020) 7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 8 China 8.1 China ALK Positive Lung Cancer Treatment Market Size (2015-2020) 8.2 ALK Positive Lung Cancer Treatment Key Players in China (2019-2020) 8.3 China ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 8.4 China ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan ALK Positive Lung Cancer Treatment Market Size (2015-2020) 9.2 ALK Positive Lung Cancer Treatment Key Players in Japan (2019-2020) 9.3 Japan ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 9.4 Japan ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia ALK Positive Lung Cancer Treatment Market Size (2015-2020) 10.2 ALK Positive Lung Cancer Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 11 India 11.1 India ALK Positive Lung Cancer Treatment Market Size (2015-2020) 11.2 ALK Positive Lung Cancer Treatment Key Players in India (2019-2020) 11.3 India ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 11.4 India ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America ALK Positive Lung Cancer Treatment Market Size (2015-2020) 12.2 ALK Positive Lung Cancer Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) 12.4 Central & South America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 F. Hoffmann-La Roche 13.1.1 F. Hoffmann-La Roche Company Details 13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue 13.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction 13.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)) 13.1.5 F. Hoffmann-La Roche Recent Development 13.2 Pfizer 13.2.1 Pfizer Company Details 13.2.2 Pfizer Business Overview and Its Total Revenue 13.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction 13.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.2.5 Pfizer Recent Development 13.3 Novartis 13.3.1 Novartis Company Details 13.3.2 Novartis Business Overview and Its Total Revenue 13.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction 13.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.3.5 Novartis Recent Development 13.4 TP Therapeutics 13.4.1 TP Therapeutics Company Details 13.4.2 TP Therapeutics Business Overview and Its Total Revenue 13.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction 13.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.4.5 TP Therapeutics Recent Development 13.5 Bristol-Myers Squibb 13.5.1 Bristol-Myers Squibb Company Details 13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction 13.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.5.5 Bristol-Myers Squibb Recent Development 13.6 Eli Lilly and Company 13.6.1 Eli Lilly and Company Company Details 13.6.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction 13.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.6.5 Eli Lilly and Company Recent Development 13.7 Takeda 13.7.1 Takeda Company Details 13.7.2 Takeda Business Overview and Its Total Revenue 13.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction 13.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.7.5 Takeda Recent Development 13.8 Beacon Pharma 13.8.1 Beacon Pharma Company Details 13.8.2 Beacon Pharma Business Overview and Its Total Revenue 13.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction 13.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) 13.8.5 Beacon Pharma Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. ALK Positive Lung Cancer Treatment Key Market Segments Table 2. Key Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue Table 3. Ranking of Global Top ALK Positive Lung Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Crizotinib Table 6. Key Players of Alectinib Table 7. Key Players of Ceritinib Table 8. Key Players of Brigatinib Table 9. Key Players of Other Table 10. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global ALK Positive Lung Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global ALK Positive Lung Cancer Treatment Market Size by Regions (2015-2020) (US$ Million) Table 13. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2015-2020) Table 14. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. ALK Positive Lung Cancer Treatment Market Growth Strategy Table 20. Main Points Interviewed from Key ALK Positive Lung Cancer Treatment Players Table 21. Global ALK Positive Lung Cancer Treatment Revenue by Players (2015-2020) (Million US$) Table 22. Global ALK Positive Lung Cancer Treatment Market Share by Players (2015-2020) Table 23. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2019) Table 24. Global ALK Positive Lung Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service Table 27. Date of Enter into ALK Positive Lung Cancer Treatment Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 30. Global ALK Positive Lung Cancer Treatment Market Size Share by Type (2015-2020) Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2021-2026) Table 32. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2015-2020) Table 33. Global ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 34. Global ALK Positive Lung Cancer Treatment Market Size Share by Application (2021-2026) Table 35. North America Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 36. North America Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 38. North America ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 40. North America ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 41. Europe Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 42. Europe Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 44. Europe ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 46. Europe ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 47. China Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 48. China Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 49. China ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 50. China ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 51. China ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 52. China ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 53. Japan Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 54. Japan Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 55. Japan ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 56. Japan ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 57. Japan ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 58. Japan ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 61. Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 63. Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 65. India Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 66. India Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 67. India ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 68. India ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 69. India ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 70. India ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 71. Central & South America Key Players ALK Positive Lung Cancer Treatment Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players ALK Positive Lung Cancer Treatment Market Share (2019-2020) Table 73. Central & South America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America ALK Positive Lung Cancer Treatment Market Share by Type (2015-2020) Table 75. Central & South America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America ALK Positive Lung Cancer Treatment Market Share by Application (2015-2020) Table 77. F. Hoffmann-La Roche Company Details Table 78. F. Hoffmann-La Roche Business Overview Table 79. F. Hoffmann-La Roche Product Table 80. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 81. F. Hoffmann-La Roche Recent Development Table 82. Pfizer Company Details Table 83. Pfizer Business Overview Table 84. Pfizer Product Table 85. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 86. Pfizer Recent Development Table 87. Novartis Company Details Table 88. Novartis Business Overview Table 89. Novartis Product Table 90. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 91. Novartis Recent Development Table 92. TP Therapeutics Company Details Table 93. TP Therapeutics Business Overview Table 94. TP Therapeutics Product Table 95. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 96. TP Therapeutics Recent Development Table 97. Bristol-Myers Squibb Company Details Table 98. Bristol-Myers Squibb Business Overview Table 99. Bristol-Myers Squibb Product Table 100. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 101. Bristol-Myers Squibb Recent Development Table 102. Eli Lilly and Company Company Details Table 103. Eli Lilly and Company Business Overview Table 104. Eli Lilly and Company Product Table 105. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 106. Eli Lilly and Company Recent Development Table 107. Takeda Company Details Table 108. Takeda Business Overview Table 109. Takeda Product Table 110. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 111. Takeda Recent Development Table 112. Beacon Pharma Business Overview Table 113. Beacon Pharma Product Table 114. Beacon Pharma Company Details Table 115. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020) (Million US$) Table 116. Beacon Pharma Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2020 VS 2026 Figure 2. Crizotinib Features Figure 3. Alectinib Features Figure 4. Ceritinib Features Figure 5. Brigatinib Features Figure 6. Other Features Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2026 Figure 8. Hospital Case Studies Figure 9. Clinics Case Studies Figure 10. Other Case Studies Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered Figure 12. Global ALK Positive Lung Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global ALK Positive Lung Cancer Treatment Market Share by Regions: 2020 VS 2026 Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2019 Figure 17. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2019 Figure 18. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2019 Figure 19. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 26. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 32. TP Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 34. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 38. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 40. Beacon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2015-2020) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

F. Hoffmann-La Roche Pfizer Novartis TP Therapeutics Bristol-Myers Squibb Eli Lilly and Company Takeda Beacon Pharma